News

AGS Recognized as a Top Workplace by U.S. News & World Report

AGS Recognized as a Top Workplace by U.S. News & World Report

AGS Honored as a Leading Workplace

AGS (NYSE: AGS), renowned as a global gaming supplier, has recently earned a prestigious accolade by being named one of the U.S. News & World Report’s Best Companies to Work For for the 2025–2026 period. This recognition marks a significant achievement as AGS stands out among more than 2,100 publicly traded companies evaluated, placing within the top 30 percent. Such recognition is not just a reflection of the company's success but also of its commitment to creating an inviting work environment.

Evaluating Workplace Excellence

The selection process for this esteemed accolade was rigorous. To qualify, companies needed to show a minimum of 75 employee reviews on Glassdoor, with feedback provided between 2021 and early 2025. Additionally, AGS was assessed based on various workplace factors that gauge employee satisfaction, including quality of pay and benefits, work-life balance, company stability, and opportunities for professional growth.

Recognitions for AGS

AGS received honors across numerous categories, further emphasizing its exceptional workplace culture. The company ranked in:

  • Best Companies to Work For – Overall
  • Best Companies to Work For in the West
  • Best Companies to Work For in the Media and Communications Industry
  • Best Companies to Work For – Top Workplace Environment
  • Best Companies to Work For – Top Engineering Jobs

Particularly notable is AGS's recognition as one of only two companies from Nevada that made the list, highlighting its commitment to providing job satisfaction for its employees in a competitive industry.

Leadership's View on Workplace Culture

“Being recognized by U.S. News & World Report is incredibly rewarding, as it reflects our employees’ sentiments regarding AGS,” commented Kim Nasuta, Senior Vice President of Human Resources. She elaborated that the numerous Glassdoor reviews showcase a narrative rooted in trust, transparency, and opportunity where employees feel understood and valued. The company fosters an environment that encourages support and empowerment, making AGS a fantastic place to work.

Further Accolades and Industry Standing

Moreover, AGS has garnered additional recognition in the industry. It was recently designated as one of the 2025 Best and Brightest Companies to Work For in the Nation and in Atlanta, and recognized as a 2025 Top Workplace in the U.S.. These accolades speak volumes about AGS's continued progression and dedication to enhancing the employee experience.

About AGS

AGS is a leading global gaming supplier dedicated to delivering diverse and entertaining gaming experiences for players across all demographics. The company began its journey focusing on the Class II Native American gaming sector and has successfully expanded its reach in the commercial gaming market. With a portfolio that includes high-performing Class II and III slot products, a comprehensive range of table games, and innovative real-money gaming platforms, AGS offers a robust value proposition for partners in the casino industry. To discover more about our extensive offerings, please visit www.playags.com.

AGS Media Contact

For further inquiries, please reach out to:
Julia Boguslawski, Chief Marketing Officer
Nikki Davis, Vice President of Marketing
PR@PlayAGS.com

Frequently Asked Questions

What is AGS recognized for?

AGS has been recognized as one of the Best Companies to Work For by U.S. News & World Report for the 2025-2026 period, noting its excellent workplace culture.

How was AGS ranked among other companies?

AGS placed in the top 30 percent out of over 2,100 evaluated publicly traded companies, showcasing its employee satisfaction.

What factors influenced AGS's recognition?

The ranking was influenced by key workplace factors such as pay, benefits, work-life balance, and career opportunities as reported by employees.

Who can I contact for press inquiries about AGS?

For press inquiries, you can contact Julia Boguslawski, Chief Marketing Officer, or Nikki Davis, Vice President of Marketing at PR@PlayAGS.com.

Where can I learn more about AGS’s offerings?

You can learn more about AGS and its gaming products by visiting their official website at www.playags.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 5

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Experience the Flavors of Portugal at the 2025 Port Wine Fest

Updated Category News Views 380

Port Wine Fest: A Celebration of Portuguese Culture The Port Wine Fest is an exciting festival dedicated to showcasing Portuguese wines and cuisine. In 2025, it will embark on its third edition with events scheduled across various vibrant cities, including San Francisco, Chicago, and New York City, creating an unforgettable experience that combines culture, food, and fine...

Continue Reading
Earnings Projections for 5E Advanced Materials to Watch

Updated Category News Views 118

Understanding 5E Advanced Materials’ Earnings Expectations 5E Advanced Materials (NASDAQ: FEAM) is gearing up to unveil its quarterly earnings report soon. Investors are keenly awaiting the details, as quarterly performance can significantly influence stock trends and market sentiment. Projected Earnings per Share Analysts are estimating an earnings per share (EPS) of...

Continue Reading
Verano Launches Adult Cannabis Sales in Connecticut's Waterbury

Updated Category News Views 111

Verano Launches Adult Use Cannabis Sales at Zen Leaf Waterbury Zen Leaf Waterbury has achieved a significant milestone by transitioning its dispensary from medical-only sales to hybrid sales, allowing for adult use cannabis sales in Connecticut. Location and Accessibility of Zen Leaf Waterbury Conveniently located at 237 East Aurora Street in Waterbury, the fifth largest...

Continue Reading
Innovative Medical Education Suite Introduced by Treatment.com AI

Updated Category News Views 176

Revolutionizing Medical Education with AI Integration Treatment.com AI Inc. is making strides in medical education by unveiling a cutting-edge platform designed to enhance clinical skills training. This innovation aims to provide a more immersive and effective educational experience for medical students. The newly launched Medical Education Suite (MES) represents a...

Continue Reading
Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Updated Category News Views 24

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Continue Reading